drugset / Trial / NCT03003000

Ibuprofen/Caffeine Lower Back or Neck Pain Study

NCT03003000

Phase 3 Completed 635 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy and safety of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet for the treatment of acute lower back or neck pain. To assess the safety and tolerability of a 400 mg ibuprofen/100 mg caffeine tablet in comparison to a 400 mg ibuprofen tablet and a placebo tablet.

Timeline

Start
2016-12-20
Primary completion
2017-09-24
Completion
2017-09-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 100 mg
Subject Ibuprofen Small molecule 400 mg

Indications

No indication recorded.